Internal Medicine, Hematology & Oncology · Flint, MI
NPI
1720076284
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
302 Kensington Ave
Flint, MI, 48503
Phone (810) 762-8400
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.0M
221,113 services
Medicare patients, 2024
488
Average age 72
Drug cost, 2024
$13.8M
4,155 prescriptions
Company payments, 2025
$7,260
From 67 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rizwan Danish was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 23,110 times for 19 patients. In total Rizwan Danish billed 221,113 services in 200 codes, and Medicare paid $4.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-02-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 23,110 | 19 | $2.31 | $53K |
| J0897 Injection, denosumab, 1 mg | Office | 10,260 | 29 | $20.53 | $211K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 7,260 | 15 | $34.82 | $253K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 4,100 | 31 | $15.91 | $65K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,826 | 56 | $0.09 | $341 |
| Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | Office | 3,725 | 13 | $31.67 | $118K |
| 85025 Blood Count | Office | 1,712 | 274 | $7.60 | $13K |
| 36415 Venipuncture Blood Collection | Office | 1,696 | 288 | $8.64 | $15K |
| 80053 Clinical Chemistry | Office | 1,031 | 216 | $10.35 | $11K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 820 | 21 | $0.69 | $567 |
| 99215 Office E&M - Established | Office | 748 | 236 | $116.22 | $87K |
| 96375 Injection Administration | Office | 671 | 76 | $10.14 | $6,805 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 530 | 29 | $0.23 | $122 |
| 96413 Chemotherapy Administration | Office | 480 | 60 | $82.61 | $40K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 448 | 16 | $0.07 | $30 |
By year: 2022 $3.1M for 310,110 services; 2023 $4.3M for 296,771 services; 2024 $4.0M for 221,113 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,712 | 274 | $7.60 | $13K |
| 36415 Venipuncture Blood Collection | 1,696 | 288 | $8.64 | $15K |
| 80053 Clinical Chemistry | 1,031 | 216 | $10.35 | $11K |
| 82784 Immunoassay | 335 | 42 | $9.11 | $3,053 |
| 88185 Surgical Pathology Examination | 291 | 11 | $15.34 | $4,464 |
| 83735 Clinical Chemistry | 195 | 50 | $6.57 | $1,281 |
| 83521 Immunoassay | 186 | 35 | $16.93 | $3,148 |
| 84443 Clinical Chemistry | 154 | 38 | $16.46 | $2,535 |
| 83540 Clinical Chemistry | 148 | 91 | $6.34 | $938 |
| 84466 Clinical Chemistry | 146 | 89 | $12.50 | $1,825 |
Medicare prescription drug claims, 2024
In 2024, the drug Rizwan Danish prescribed most often to Medicare patients was Anastrozole, with 303 prescriptions and refills. In total Rizwan Danish wrote 4,155 Medicare prescriptions that cost $13.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 303 | 758 | 90 | $17K |
| Acyclovir Generic | 206 | 270 | 58 | $2,584 |
| Prochlorperazine Maleate Generic | 204 | 207 | 103 | $6,538 |
| Dexamethasone Generic | 180 | 263 | 82 | $4,096 |
| Erleada Apalutamide | 180 | 184 | 20 | $2.8M |
| Ondansetron Hcl Generic | 158 | 158 | 64 | $708 |
| Ondansetron Odt Ondansetron | 150 | 153 | 74 | $1,380 |
| Prednisone Generic | 145 | 224 | 54 | $1,196 |
| Tamoxifen Citrate Generic | 144 | 337 | 39 | $5,387 |
| Eliquis Apixaban | 135 | 255 | 43 | $140K |
| Olanzapine Generic | 128 | 157 | 50 | $1,721 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 102 | 138 | 34 | $316 |
| Allopurinol Generic | 95 | 179 | 32 | $1,009 |
| Warfarin Sodium Generic | 87 | 157 | 17 | $930 |
| Hydroxyurea Generic | 85 | 198 | 26 | $4,647 |
Brand drugs: - claims; generic drugs: 3,048 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rizwan Danish $7,260 ($7,260 in general payments such as food, travel and fees) from 67 companies. The largest payer was Novartis Pharmaceuticals Corporation with $885.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 26 | $885 |
| Janssen Biotech, Inc. JNJ | 29 | $445 |
| AstraZeneca Pharmaceuticals LP AZN | 19 | $359 |
| Genentech USA, Inc. ROG.SW | 17 | $346 |
| Merck Sharp & Dohme LLC MRK | 12 | $295 |
| Astellas Pharma US Inc 4503.T | 10 | $280 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $253 |
| Abbvie Inc. ABBV | 9 | $223 |
| Daiichi Sankyo Inc. 4568.T | 10 | $220 |
| Legend Biotech USA Inc. LEGN | 9 | $216 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.